Advertise

Mergers and Acquisitions Briefing

Mergers and Acquisitions Briefing

With a rise in consumer confidence and other factors, 2014 is proving to be a more stable year for investors. This has led to an increase in mergers and acquisitions. The New York Times reported on Monday that for Wall Street, 2014 is likely to be one of the biggest years for big deals. Mergers worth over $100 billion were made on Monday, with Actavis paying $66 billion for Botox-maker Allergan, and Halliburton coughing up $34.6 billion for oilfield services firm, Baker Hughes. Analysts suggest the rise in these sort of deals is due to low borrowing costs and share prices just starting to rise.
Global law firm, Baker & Mckenzie, announced on Tuesday that Europe once again leads the way for its M&A activity in Latin America. 42% of the activity came from Europe with only 34% from North America. Some of Europe’s biggest acquisitions in the region include the $638 million deal from Alliance Boots for 2 large retail networks, and a $600 million deal from Belgium’s Nyrstar. One of the biggest acquisitions that did not take place this year was Pfizer’s bid for AstraZeneca. On Tuesday thelatter firm showed that it has a strong independent future of its own after showing off a new line of cancer drugs to investors.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...
Exclusive email insights, members-only careers events, insider tips and more.